Brown, D L <br/><br/>
Deaths associated with platelet glycoprotein IIb/IIIa inhibitor treatment.  [electronic resource] 

 -  Heart (British Cardiac Society)  May 2003 
 - 535-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1468-201X 
<br/><br/><label>Standard No.: </label>10.1136/heart.89.5.535  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Adult<br/>Adverse Drug Reaction Reporting Systems<br/>Aged<br/>Aged, 80 and over<br/>Angioplasty, Balloon, Coronary<br/>Antibodies, Monoclonal--adverse effects<br/>Death, Sudden--etiology<br/>Eptifibatide<br/>Female<br/>Hemorrhage--chemically induced<br/>Humans<br/>Immunoglobulin Fab Fragments--adverse effects<br/>Male<br/>Middle Aged<br/>Myocardial Ischemia--drug therapy<br/>Peptides--adverse effects<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Risk Factors<br/>Tirofiban<br/>Tyrosine--adverse effects